Live Breaking News & Updates on Professor Peter Bauer

Stay updated with breaking news from Professor peter bauer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients

Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher diseaseCould predict clinical course of patients and improve personalized care CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2023 (GLOBE NEWSWIRE) CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data confirming the ....

Peter Bauer , United Kingdom , Lennart Streibel , Melissa Hall , Drug Administration , Exchange Commission , Corporate Communications , Professor Peter Bauer , Clinical Neurogenetics , Newborn Screening , Insight Reports , Gaucher Disease , Neurodegenerative Diseases , Aucher Patients , Disease Severity , Centogene Biodatabank ,

Centogene N.V. (CNTG) Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patient

Centogene N.V. (CNTG) Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patient
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Peter Bauer , Melissa Hallcorporate Communications , Drug Administration , Exchange Commission , Professor Peter Bauer , Clinical Neurogenetics , Newborn Screening , Insight Reports ,

CENTOGENE Announces Publication Establishing Lyso-Gb1 as a

Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher. ....

United Kingdom , Peter Bauer , Melissa Hall , Lennart Streibel , Drug Administration , Corporate Communications , Exchange Commission , Professor Peter Bauer , Clinical Neurogenetics , Newborn Screening , Insight Reports , Nasdaq Cntg , Entogene Nv ,

Centogene Announces Publication Establishing Lyso-Gb1 As A Predictive Biomarker For Gaucher Disease Patients

Centogene Announces Publication Establishing Lyso-Gb1 As A Predictive Biomarker For Gaucher Disease Patients
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Peter Bauer , Tobias Bo , Professor Peter Bauer , Genomic Officer , Clinical Neurogenetics , Newborn Screening , Insight Reports ,

CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort

Results Published in European Journal of Human Genetics Demonstrate Unprecedented Insights to Accelerate Potential Treatment OptionsInclusion of 602 patients from 47 countries represents the world’s. ....

United Kingdom , United States , Peter Bauer , Aida Bertoli Avella , Lennart Streibel , Melissa Hall , Exchange Commission , Drug Administration , International Niemann , Head Of Research Data Analysis , Corporate Communications , Results Published , European Journal , Human Genetics Demonstrate Unprecedented Insights , Accelerate Potential Treatment , Likely Pathogenic , Human Genetics , Professor Peter Bauer , Human Phenotype Ontology , Research Data Analysis , Middle East , International Niemann Pick Disease Registry , Insight Reports ,